company background image
37S0 logo

Spineway BST:37S0 Stock Report

Last Price

€0.084

Market Cap

€70.8k

7D

0%

1Y

-98.8%

Updated

22 Dec, 2024

Data

Company Financials +

37S0 Stock Overview

Engages in the design, manufacture, and marketing of implants and surgical instruments for treating disorder of spinal column. More details

37S0 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth1/6
Past Performance0/6
Financial Health4/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Spineway SA Competitors

Price History & Performance

Summary of share price highs, lows and changes for Spineway
Historical stock prices
Current Share Price€0.084
52 Week High€28.20
52 Week Low€0.072
Beta1.47
1 Month Change-10.26%
3 Month Changen/a
1 Year Change-98.83%
3 Year Change-100.00%
5 Year Change-100.00%
Change since IPO-100.00%

Recent News & Updates

Recent updates

Shareholder Returns

37S0DE Medical EquipmentDE Market
7D0%-2.9%-2.6%
1Y-98.8%-8.5%6.9%

Return vs Industry: 37S0 underperformed the German Medical Equipment industry which returned -8.5% over the past year.

Return vs Market: 37S0 underperformed the German Market which returned 6.9% over the past year.

Price Volatility

Is 37S0's price volatile compared to industry and market?
37S0 volatility
37S0 Average Weekly Movementn/a
Medical Equipment Industry Average Movement6.6%
Market Average Movement4.8%
10% most volatile stocks in DE Market11.2%
10% least volatile stocks in DE Market2.4%

Stable Share Price: 37S0's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine 37S0's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
200548Stephane Le Rouxwww.spineway.com

Spineway SA engages in the design, manufacture, and marketing of implants and surgical instruments for treating disorder of spinal column. The company offers ayers rock, an anterior cervical interbody fusion cage; blue mountain, an anterior cervical interbody fusion plate; mont blanc, a posterior thoracolumbar pedicle screws; mont blanc baby, a pediatric growing rod system; mont blanc 3d+, a coplanar alignment system; posterior osteosynthesis systems; kili, an anterior lumbar interbody fusion cage; twin peaks plif posterior lumbar interbody fusion cages; twin peaks tlif transforaminal lumbar interbody fusion cages; and mont blanc mis, a mini-invasive thoracolumbar system. It also provides neve, a biomaterial bone substitute for bone regeneration; and cervical and lumbar prosthesis elastic spine pads.

Spineway SA Fundamentals Summary

How do Spineway's earnings and revenue compare to its market cap?
37S0 fundamental statistics
Market cap€70.80k
Earnings (TTM)-€8.00m
Revenue (TTM)€11.99m

0.0x

P/S Ratio

0.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
37S0 income statement (TTM)
Revenue€11.99m
Cost of Revenue€9.32m
Gross Profit€2.67m
Other Expenses€10.67m
Earnings-€8.00m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-9.60
Gross Margin22.26%
Net Profit Margin-66.71%
Debt/Equity Ratio8.8%

How did 37S0 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 00:26
End of Day Share Price 2024/12/06 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Spineway SA is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Arnaud GuérinPortzamparc BNP Paribas
Mohamed KaabouniPortzamparc BNP Paribas